Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
[2] Signs and symptoms [edit] Characteristics include a blue/black stain of skin initially
Checklist for document scope, quotation units, packaging, MOQ, and lead time review
Fast, Free Shipping: The vendor extends free U.S
Key Benefits Observed in Clinical Trials Treatment of Erythropoietic Protoporphyria (EPP): MT-1 (Afamelanotide) is FDA-approved for use in patients with EPP, a rare genetic disorder that causes extreme photosensitivity, leading to severe pain and skin damage upon light exposure
doi:10.1007/s11940-016-0429-y
US$ 22.72
US$ 28.50
US$ 20.37
US$ 22.95
US$ 20.94
